Abstract
Introduction
Although controversial, the use of breast magnetic resonance imaging (MRI) is widespread. We sought to determine factors that influenced its use in a population-based sample.
Methods
The National Health Interview Survey is conducted annually by the Centers for Disease Control and is designed to be representative of the American population. Data from 2010 were queried for the use of breast MRI and associated sociodemographic and risk characteristics.
Results
Of the 11,222 women aged ≥30 years who were surveyed, 4.7 % reported ever having a breast MRI. Nearly a quarter were done as part of a “routine exam” and <5 % were done for “family history” or for “high risk.” Factors correlating with MRI use on univariate analysis included age, race, personal and/or family history of breast cancer, history of benign breast biopsy, perceived risk, and insurance. On multivariate analysis, African-American race (p = 0.001), personal history (p < 0.001), history of benign biopsy (p < 0.001), and high perceived risk (p < 0.001) were significantly associated with increased MRI use. In a cohort without a personal history of breast cancer, race, history of benign biopsy, and perceived risk were independent correlates of breast MRI, whereas family history, age, and insurance were no longer significant.
Conclusions
Personal history is the strongest factor associated with breast MRI use. However, whereas race, history of benign biopsy, and perceived risk were independently associated with MRI use, family history was not. These findings call into question whether current practice patterns follow evidence-based guidelines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines 2012. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection. Accessed 25 Feb 2012.
Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180-7.
Hwang N, Schiller DE, Crystal P, et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: Its effect on ipsilateral breast tumor recurrence after breast conservation therapy. Ann Surg Oncol. 2009;16(11):3000-9.
Katipamula R, Degnim AC, Hoskin T, et al. Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging J Clin Oncol. 2009;27(25):4082-8.
Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011;2561(2):421-7.
Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am. 2010;19(3):475-92.
Kuhl CK, Scrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:458-92.
Thornton H. Should we undertake an MRI breast screening trial? Lancet. 2007;370:1903.
Heywang SH, Wolf A, Pruss E, Hilbertz T Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989;171(1):95-103.
D’Orsi CJ, Newell MS. On the frontline of screening for breast cancer. Sem Oncol. 2011;38(1):119-27.
Kaiser WA, Zeitler E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA-preliminary observations. Radiology. 1989;179:681-6.
Graubard BI, Freedman AN, Gail MH. Five-year and lifetime risk of breast cancer among U.S. Subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev. 2010;19:2428-9.
Breastcncer.org. US breast cancer statistics. http://www.breastcancer.org/symptoms/understand_bc/statistics.jsp. Accessed 10 March 2012.
Gorechlad JW, McCabe EB, Higgins JH, Likosky DS, Lewis PJ, Rosenkranz KM, Barth RJ. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for breast MRI? Ann Surg Oncol. 2008;15(6):1703-9.
Kriege, M, Brekelmans, CT, Boetes, C, Besnard, PE, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004:351:427-37.
Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-25.
Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-76.
Ickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357.
Sommer, CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS. Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170:77–83.
El-Bastawissi AY, White E, Mandelson MT, Taplin S. Variation in mammographic breast density by race. Ann Epidemiol. 2001;11(4):257-63.
Disclosure
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killelea, B.K., Lannin, D.R., Horvath, L.J. et al. Factors Associated with Breast MRI Use: A Population-Based Analysis. Ann Surg Oncol 20, 1798–1805 (2013). https://doi.org/10.1245/s10434-012-2758-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-012-2758-8